Results 21 to 30 of about 4,941,532 (395)

Drug prescription support in dental clinics through drug corpus mining [PDF]

, 2018
The rapid increase in the volume and variety of data poses a challenge to safe drug prescription for the dentist. The increasing number of patients that take multiple drugs further exerts pressure on the dentist to make the right decision at point-of ...
Goh, Wee Pheng, Tao, Xiaohui, Zhang, Ji, Yong, Jianming, Zhang, Wenping, Xie, Haoran   +5 more
core   +5 more sources

Crystal structure of (1E,1′E)-4,4′-(9,9-diethyl-9H-fluorene-2,7-diyl)dibenzaldehyde dioxime, C31H28N2O2

Zeitschrift für Kristallographie - New Crystal Structures, 2023
C31H28N2O2, triclinic, P1‾$P\overline{1}$ (no. 2), a = 9.0809(9) Å, b = 9.2626(9) Å, c = 14.8540(15) Å, α = 93.574(8)°, β = 98.554(8)°, γ = 99.558(8)°, V = 99.558(8) Å3, Z = 2, Rgt(F) = 0.0541, wRref(F2) = 0.1424, T = 293(2) K.
Ma Ying-Hong, Zhao Hong-Yan, Tian Yu, Wu Yi, Wang Lei   +4 more
doaj   +1 more source

Non-medical prescription opioid use predicts injection initiation among street-involved youth. [PDF]

Int J Drug Policy, 2016
DeBeck K, Wood E, Dong H, Dobrer S, Hayashi K, Montaner J, Kerr T.   +6 more
europepmc   +3 more sources

Crystal structure and anti-inflammatory activity of (3E,5E)-3,5-bis(2-fluorobenzylidene)-1-((4-fluorophenyl)sulfonyl)piperidin-4-one, C25H18F3NO3S

Zeitschrift für Kristallographie - New Crystal Structures, 2020
C25H18F3NO3S, orthorhombic, Pca21 (no. 29), a = 19.1142(7) Å, b = 11.6722(5) Å, c = 9.2390(3) Å, V = 2061.26(13) Å3, Z = 4, Rgt(F) = 0.0422, wRref(F2) = 0.0974, T = 100.02(10) K.
Zhang Jia-Jing, Chen Dian-Xing, Lv Liang-Yan, Qi Cong-Hui, Xu Wei-Cheng, Hou Gui-Ge   +5 more
doaj   +1 more source

Crystal structure of (3E,5E)-1-(4-cyanobenzenesulfonyl)-3,5-bis(3-fluorobenzylidene)piperidin-4-one-dichloromethane (1/1), C27H20Cl2F2N2O3S

Zeitschrift für Kristallographie - New Crystal Structures, 2021
C27H20Cl2F2N2O3S, triclinic, P1‾$P‾{1}$ (no. 2), a = 8.7887(4) Å, b = 11.2517(6) Å, c = 13.7609(7) Å, α = 74.962(4)°, β = 81.084(4)°, γ = 71.259(4)°, V = 1240.68(11) Å3, Z = 2, Rgt(F) = 0.0582, wRref(F2) = 0.1543, T = 100.0(1) K.
Gao Zhong-Fei, Wang Lei, Hou Gui-Ge, Wang Chun-Hua   +3 more
doaj   +1 more source

Crystal structure of 9-(2-chloroethoxy)-4-(4-methoxy-3-(trifluoromethyl)phenyl)- 5,6-dihydrobenzo[h]quinazolin-2-amine, C22H19ClF3N3O2

Zeitschrift für Kristallographie - New Crystal Structures, 2023
C22H19ClF3N3O2, triclinic, P1‾$P\overline{1}$ (no. 2), a = 9.8138(7) Å, b = 10.9739(7) Å, c = 11.6878(9) Å, α = 62.633(7)°, β = 67.095(7)°, γ = 68.817(6)°, V = 1003.78(14) Å3, Z = 2, Rgt(F) = 0.0454, wRref(F2) = 0.1158, T = 293 K.
Li Rong-Kai, Wang Chun-Hua, Hou Gui-Ge, Li Cheng-Bo   +3 more
doaj   +1 more source

Crystal structure of (E)-7-bromo-2-(4-(4-methylpiperazin-1-yl)benzylidene)-3,4-dihydronaphthalen-1(2H)-one, C22H23BrN2O

Zeitschrift für Kristallographie - New Crystal Structures, 2023
C22H23BrN2O, triclinic, P1‾$P\overline{1}$ (no. 2), a = 10.0543(1) Å, b = 11.4893(1) Å, c = 16.5853(1) Å, α = 93.152(1)°, β = 91.877(1)°, γ = 97.097(1)°, V = 1896.81(3) Å3, Z = 4, Rgt(F) = 0.0318, wRref(F2) = 0.0840, T = 293 K.
Qi Qin-Bing, Li Wen-Xuan, Hou Gui-Ge, Li Cheng-Bo   +3 more
doaj   +1 more source

Crystal structure of 9-bromo-4-(6-methoxypyridin-2-yl)-5,6-dihydrobenzo[h]quinazolin- 2-amine, C18H15BrN4O

Zeitschrift für Kristallographie - New Crystal Structures, 2022
C18H15BrN4O, monoclinic, P21/c (no. 14), a = 10.5097(7) Å, b = 6.6990(5) Å, c = 23.5623(15) Å, β = 92.038(6)°, V = 1657.8(2) Å3, Z = 4, R gt(F) = 0.0393, wR ref(F 2) = 0.0863, T = 150.00(10) K.
Li Wenxuan, Wang Lei, Jiang Nan, Hou Guige, Liu Yongjun   +4 more
doaj   +1 more source

An inevitable wave of prescription drug monitoring programs in the context of prescription opioids: pros, cons and tensions [PDF]

, 2014
BACKGROUND: In an effort to control non-medical use and/or medical abuse of prescription drugs, particularly prescription opioids, electronic prescription drug monitoring programs (PDMP) have been introduced in North-American countries, Australia and ...
Islam, M. Mofizul, McRae, Ian S.
core   +2 more sources

Crystal structure and anti-inflammatory activity of (3E,5E)-3-(2-fluorobenzylidene)-1-((4-acetamidophenyl)sulfonyl)-5-(pyridin-3-ylmethylene)piperidin-4-one-methanol-hydrate (2/1/1), C53H50F2N6O10S2

Zeitschrift für Kristallographie - New Crystal Structures, 2020
C53H50F2N6O10S2, monoclinic, P21/n (no. 14), a = 15.088(5) Å, b = 23.560(9) Å, c = 15.401(6) Å, β = 112.254(5)°, V = 5067(3) Å3, Z = 4, Rgt(F) = 0.0509, wRref(F2) = 0.1336, T = 298(2) K.
Wang An-Qi, Gao Ru-Ning, Luan Qing-Hao, Wang Ze-Ping, Li Xiao-Ming, Hou Gui-Ge   +5 more
doaj   +1 more source